Redsense Medical AB (publ) (NGM: REDS)
Sweden
· Delayed Price · Currency is SEK 6.90
0.00 (0.00%)
At close: Nov 20, 2024
Redsense Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 24.49 | 25.52 | 16.75 | 16.34 | 17.1 | 14.23 | Upgrade
|
| Other Revenue | - | - | 0 | - | - | - | Upgrade
|
| Revenue | 24.49 | 25.52 | 16.75 | 16.34 | 17.1 | 14.23 | Upgrade
|
| Revenue Growth (YoY) | 10.81% | 52.32% | 2.51% | -4.43% | 20.19% | 63.51% | Upgrade
|
| Cost of Revenue | 10.13 | 12.36 | 5.49 | 5.95 | 7.14 | 6.3 | Upgrade
|
| Gross Profit | 14.36 | 13.16 | 11.27 | 10.4 | 9.96 | 7.93 | Upgrade
|
| Selling, General & Admin | 19.13 | 17.54 | 22.46 | 22.77 | 16.6 | 12.93 | Upgrade
|
| Other Operating Expenses | -0.9 | 0.59 | -1.04 | -0.56 | 1.25 | -0.6 | Upgrade
|
| Operating Expenses | 18.29 | 18.2 | 21.47 | 22.39 | 18.08 | 12.53 | Upgrade
|
| Operating Income | -3.93 | -5.04 | -10.21 | -11.99 | -8.12 | -4.59 | Upgrade
|
| Interest Expense | -0.54 | -0.03 | -0.1 | -0.05 | -0.04 | -0.48 | Upgrade
|
| Interest & Investment Income | - | 0.06 | 1.02 | 1.05 | 0.16 | - | Upgrade
|
| Earnings From Equity Investments | - | - | - | -0.3 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 2.5 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | - | -0 | 0 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -4.47 | -5.01 | -6.79 | -11.29 | -8.01 | -5.07 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.5 | 0.5 | -1.97 | 3.32 | -1.03 | - | Upgrade
|
| Pretax Income | -3.98 | -4.51 | -8.76 | -7.97 | -9.03 | -5.07 | Upgrade
|
| Net Income | -3.98 | -4.51 | -8.76 | -7.97 | -9.03 | -5.07 | Upgrade
|
| Net Income to Common | -3.98 | -4.51 | -8.76 | -7.97 | -9.03 | -5.07 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 14 | 14 | 14 | 14 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 14 | 14 | 14 | 14 | 12 | Upgrade
|
| Shares Change (YoY) | 4.52% | -0.16% | 0.61% | - | 15.33% | 10.90% | Upgrade
|
| EPS (Basic) | -0.27 | -0.32 | -0.62 | -0.57 | -0.64 | -0.42 | Upgrade
|
| EPS (Diluted) | -0.27 | -0.32 | -0.62 | -0.57 | -0.64 | -0.42 | Upgrade
|
| Free Cash Flow | -12.73 | -5.1 | -9.83 | -12.58 | -6.64 | -9.79 | Upgrade
|
| Free Cash Flow Per Share | -0.86 | -0.36 | -0.70 | -0.90 | -0.47 | -0.80 | Upgrade
|
| Dividend Per Share | - | - | - | - | 2.140 | - | Upgrade
|
| Gross Margin | 58.63% | 51.56% | 67.24% | 63.63% | 58.22% | 55.76% | Upgrade
|
| Operating Margin | -16.05% | -19.74% | -60.93% | -73.37% | -47.50% | -32.28% | Upgrade
|
| Profit Margin | -16.24% | -17.68% | -52.27% | -48.78% | -52.83% | -35.64% | Upgrade
|
| Free Cash Flow Margin | -51.98% | -20.00% | -58.68% | -76.98% | -38.85% | -68.77% | Upgrade
|
| EBITDA | -3.87 | -4.98 | -10.16 | -11.97 | -8.09 | -4.59 | Upgrade
|
| EBITDA Margin | -15.79% | -19.50% | -60.61% | -73.21% | -47.33% | -32.27% | Upgrade
|
| D&A For EBITDA | 0.06 | 0.06 | 0.05 | 0.03 | 0.03 | 0 | Upgrade
|
| EBIT | -3.93 | -5.04 | -10.21 | -11.99 | -8.12 | -4.59 | Upgrade
|
| EBIT Margin | -16.05% | -19.74% | -60.93% | -73.37% | -47.50% | -32.28% | Upgrade
|
| Revenue as Reported | 26.55 | 25.56 | 17.79 | 16.9 | 17.15 | 14.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.